In terms of obesity and metabolic syndrome, a fair number of the trials showed that fecal microbiome transplantation did not affect clinical parameters, including BMI, even though it partially improved peripheral insulin sensitivity, suggesting that a short duration of the intervention should be considered (98). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.